References
- Bischoff K. B., Dedrick R. L., Zaharko D. S., Longstreth J. A. Methotrexate pharmacokinetics. Journal of Pharmaceutical Sciences 1971; 60: 1128–1133
- Blom A., Scaf A. H., Meijer D. K. Hepatic drug transport in the rat. Biochemical Pharmacology 1982; 31: 1553–1565
- Bäärnhielm C., Dahlbäck H., Skånberg I. In vivo pharmacokinetics of felodipine predicted from in vitro studies in rat, dog and man. Acta Pharmacologica et Toxicologica 1986; 58: 501–510
- Bäärnhielm C., Skånberg I., Borg K. O. Cytochrome P-450-dependent oxidation of felodipine—a 1, 4-dihydropyridine—to the corresponding pyridine. Xenobiotica 1984; 14: 719–726
- Colburn W. A., Berkersky I., Min B. H., Hodshon B. J., Garland W. A. Contribution of gut contents, intestinal wall and liver to the first-pass metabolism of clonazepam in the rat. Research Communications in Chemical Pathology and Pharmacology 1980; 27: 73–90
- Cotler S., Bugge C. J., Colburn W. A. Role of gut contents, intestinal wall, and liver on the first pass metabolism and absolute bioavailability of isotretinoin in the dog. Drug Metabolism and Disposition 1983; 11: 458–462
- Edgar B., Regårdh C. G., Johnsson G., Johansson L., Lundborg P., Löfberg I., Rönn O. Felodipine kinetics in healthy men. Clinical Pharmacology and Therapeutics 1985; 38: 205–211
- Hirom P. C., Millburn P., Smith R. L. Bile and urine as complementary pathways for the excretion of foreign organic compounds. Xenobiotica 1976; 6: 55–64
- Hoffmann K.-J., Weidolf L. Identification of felodipine metabolites in rat urine. Biomedical Mass Spectrometry 1985; 12: 414–423
- Huckle K. R., Chipman J. K., Hutson D. H., Millburn P. Metabolism of 3-phenoxybenzoic acid and the enterohepatorenal disposition of its metabolites in the rat. Drug Metabolism and Disposition 1981; 9: 360–368
- Klippert P. J., Noordhoek J. The area under the curve of metabolites for drugs and metabolites cleared by the liver and extrahepatic organs. Drug Metabolism and Disposition 1985; 13: 97–101
- Lin J. H., Yeh K. C., Duggan D. E. Effect of enterohepatic circulation on the pharmacokinetics of diflunisal in rats. Drug Metabolism and Disposition 1985; 13: 321–326
- Pang S. K., Gillette J. R. A theoretical examination of the effects of gut wall metabolism, hepatic elimination, and enterohepatic recycling on estimates of bioavailability and of hepatic blood flow. Journal of Pharmacokinetics and Biopharmaceutics 1978; 6: 355–367
- Sheiner L. B., Beal S. L. Pharmacokinetic parameter estimates from several least squares procedures: Supervarity of extended least squares. Journal of Pharmacokinetics and Biopharmaceutics 1985; 13: 185–201
- Tse F. L., Ballard F., Skinn J. Estimating the fraction reabsorbed in drugs undergoing enterohepatic circulation. Journal of Pharmacokinetics and Biopharmaceutics 1982; 10: 455–461
- Waller D. G., Renwick A. G., Gruchy B. S., George C. E. The first pass metabolism of nifedipine in man. British Journal of Clinical Pharmacology 1984; 18: 951–954
- Weidolf L., Borg K. O., Hoffmann K.-J. Urinary metabolites of felodipine, a new vasodilator drug, in man, dog, rat, and mouse. Xenobiotica 1984; 14: 657–666
- Yamaoka K., Nakagawa T., Uno T. Statistical moments in pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics 1978; 6: 547–558